Oruka Therapeutics, INC S-1 registration statements
Registration statements, filed ahead of a public offering, with the business description and financials a first-time investor sees.
NASDAQ
Oruka Therapeutics has filed a registration statement for the resale of up to 8.7 million shares of its common stock by selling stockholders, following a recent private placement.